Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Effect of Add-On Buprenorphine to Matrix Program in Reduction of Craving and Relapse Among People With Methamphetamine Use Disorder: A Randomized Controlled Trial Publisher Pubmed



Kheirabadi GR1 ; Bahrami M2 ; Shariat A2 ; Tarrahi M3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Behavioral Sciences Research Center
  2. 2. Department of Psychiatry, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Department of Statistic and Epidemiology, School of Public Health, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Journal of Clinical Psychopharmacology Published:2021


Abstract

Background Methamphetamine addiction is a global issue. Buprenorphine might have beneficial roles in reducing craving to methamphetamine use via altering neurotransmission signaling and dopaminergic system-related reward mechanisms. Procedures This clinical trial was performed in 2019 to 2020 in Khorshid Hospital, Isfahan, Iran. The study was conducted on patients with methamphetamine use disorder. The intervention group received sublingual buprenorphine for 8 weeks, and the other group also received placebo tablets. Patients were followed up and visited every month for the next 4 months. Both groups were treated simultaneously by matrix program for 2 months and observed for the next 4 months. Patients filled out the Cocaine Craving Questionnaire-Brief (CCQ-Brief) every week during intervention time (first 2 months) and every month during follow up visits (4 months). The Depression Anxiety Stress Scale (DASS-21) was also filled out before and after interventions for all of the patients. Data were analyzed using SPSS software using χ2, independent t test and repeated-measure analysis of variance tests. Results Our data indicated significantly lower CCQ-Brief scores in the intervention group compared with the placebo group (P < 0.05). It was also indicated that changes in CCQ-Brief scores were also significant among both groups (P < 0.001). We also showed that the anxiety, depression, and stress scores reduced significantly after interventions (P < 0.001). These scores were also significantly lower in the intervention group compared with placebo group (P < 0.05). Conclusions Buprenorphine may be effective and may have positive potential roles in reducing methamphetamine craving. This drug is also helpful in reducing the anxiety, depression, and stress of patients with methamphetamine use disorders. © Wolters Kluwer Health, Inc. All rights reserved.
Related Docs
View other Related Docs
1. The Effect of Perphenazine Add-On Therapy to Matrix Intervention on Control of Craving and Relapse in Methamphetamine Users: A Randomized Controlled Trial, International Journal of High Risk Behaviors and Addiction (2022)
2. The Effect of Buprenorphine on Methamphetamine Cravings, Journal of Clinical Psychopharmacology (2015)
3. Sustained-Release Methylphenidate in Methamphetamine Dependence Treatment: A Double-Blind and Placebo-Controlled Trial, DARU, Journal of Pharmaceutical Sciences (2015)
4. The Effects of Oxytocin on Craving, Mental Health Parameters, and Stress Hormones in Methamphetamine-Dependent Patients Undergoing Matrix Treatment Model: A Randomized, Double-Blind Clinical Trial, European Addiction Research (2022)
5. Tramadol Versus Methadone for the Management of Acute Opioid Withdrawal: An Add-On Study, Journal of Research in Medical Sciences (2006)
6. The Effect of Adding Memantine to Clonidine in Reducing Withdrawal Symptoms in Opioid-Dependent Patients: A Double-Blind Randomized Controlled Trial, Journal of Clinical Psychopharmacology (2021)
7. The Efficacy of N-Acetylcysteine in the Treatment of Methamphetamine Dependence: A Double-Blind Controlled, Crossover Study, Archives of Iranian Medicine (2015)
8. The Effect of Matrix Model on Depression, Anxiety, and Quality of Life in Methamphetamine Users and Their Caregivers, Addictive Disorders and their Treatment (2018)
Experts (# of related papers)
View all Related Experts
Hojatallah Alaei (15)
Gholam Reza Kheirabadi (11)
Other Related Docs
9. Effectiveness of Relapse Prevention Cognitive- Behavioral Model in Opioid -Dependent Patients Participating in the Methadone Maintenance Treatment in Iran, Iranian Journal of Public Health (2013)
10. Executive Functions in Methamphetamine and Heroin Users Versus Non-Users, Journal of Isfahan Medical School (2013)
11. Risk and Protective Factors Affecting Drug Craving Among Patients With Substance Use Disorders Undergoing Opioid Agonists Maintenance Therapy, Substance Use and Misuse (2023)
12. Use of Amphetamine-Type Stimulants in the Islamic Republic of Iran, 2004–2015: A Review; [Consommation De Stimulants De Type Amphetamines En Republique Islamique D’Iran, 2004-2005: Analyse], Eastern Mediterranean Health Journal (2017)
13. The Effect of Am281, a Cannabinoid Antagonist, on Memory Performance During Spontaneous Morphine Withdrawal in Mice, Research in Pharmaceutical Sciences (2013)
14. Naltrexone in Unintentional Methadone Poisoning, Journal of Isfahan Medical School (2016)
15. Effect of Opium Versus Methadone on Polysomnographic Characteristics of Patients With Obesity Hypoventilation Syndrome, Basic and Clinical Neuroscience (2024)
16. Ascorbic Acid Decreases Morphine Self-Administration and Withdrawal Symptoms in Rats, Pathophysiology (2005)
17. Cultural Adaptation and Validation of the Barratt Impulsiveness Scale (Bis) in a Population of Iranian Drug and Alcohol Addicts, Environment and Social Psychology (2024)
18. Effects of Treadmill Exercise and Chronic Stress on Anxiety-Like Behavior, Neuronal Activity, and Oxidative Stress in Basolateral Amygdala in Morphine-Treated Rats, Synapse (2023)
19. Self-Esteem and Locus of Control in the Initial and Final Stages of Drug Withdrawal Among Addicts Attending Rehabilitation Centers, Rawal Medical Journal (2018)
20. Social Cognitive Theory As a Theoretical Framework to Predict Sustained Abstinence 6 Months After Substance Use Treatment, Journal of Substance Use (2018)
21. A Comparative Study of the Effectiveness of Acceptance and Commitment Therapy and Transcranial Direct Current Stimulation on Anxiety, Depression, and Physical Symptoms of Individuals Suffering From Chronic Pain, Journal of Biomolecular Techniques (2022)
22. Personality Traits and Their Relationship to Demographic Features in Addicts Referring to a Drug Rehabilitation Center in the City of Isfahan, Iran, Iranian Journal of Public Health (2015)
23. Evaluation of Medical Prefrontal Cortex (Mpfc) Stimulation and Destruction Effects on Addiction to Morphine, Journal of Isfahan Medical School (2013)
24. Microinjection of a Dopamine-D1 Receptor Agonist Into the Ventral Tegmental Area Reverses the Blocked Expression of Morphine Conditioned Place Preference by N-Methyl-D-Aspartate Receptor Antagonist, Advanced Biomedical Research (2020)
25. Ascorbate Reduces Morphine-Induced Extracellular Dopac Level in the Nucleus Accumbens: A Microdialysis Study in Rats, Brain Research (2005)
26. Cannabis and Opium Abuse Patterns and Their Associated Complications in a Sample of Young Iranians, Journal of Child and Adolescent Substance Abuse (2012)
27. Pregabalin Does Not Reduce Opioid Withdrawal Symptoms: A Randomized Controlled Trial, Addictive Disorders and their Treatment (2019)
28. Comparison of the Efficacy of Methadone and Tramadol in Opioid-Assisted Detoxification, Iranian Journal of Medical Sciences (2007)
29. Blockade of Prelimbic Glutamate Receptor Reduces the Reinforcing Effect of Morphine, Canadian Journal of Physiology and Pharmacology (2018)
30. Prevalence of Gastrointestinal Symptoms in Opioid Consumers Referring to Methadone Maintenance Treatment (Mmt) Clinics in Isfahan, Iran, Journal of Isfahan Medical School (2013)
31. Comparing Opium Tincture and Methadone for Medication-Assisted Treatment of Patients With Opioid Use Disorder: Protocol for a Multicenter Parallel Group Noninferiority Double-Blind Randomized Controlled Trial, International Journal of Methods in Psychiatric Research (2019)
32. Predictors of Motivation for Substance Abuse Treatment in a Sample of Iranian Addicts, Journal of Substance Use (2017)
33. Investigating the Effect of Zinc Supplementation on Probability of Relapse and Mental Health in Patients With Opioid Use Disorder Undergoing Methadone Maintenance Treatment, Substance Abuse: Treatment, Prevention, and Policy (2023)
34. Seeking Safety Therapy for Co-Occurring Posttraumatic Stress Disorder and Substance Use Disorder: A Case Study in Iran, International Journal of High Risk Behaviors and Addiction (2018)
35. Predictors of Treatment Retention in a Major Methadone Maintenance Treatment Program in Iran: A Survival Analysis, Journal of Research in Health Sciences (2014)
36. Opium Tincture Versus Methadone for Opioid Agonist Treatment: A Randomized Controlled Trial, Addiction (2023)
37. The Efficacy of Plissit As Adjuvant Therapy With Bupropion on Sexual Dysfunction and Marital Satisfaction Among Men Patients on Methadone Maintenance Therapy, Journal of Isfahan Medical School (2018)
38. Predictors of Time to Relapse in Amphetamine-Type Substance Users in the Matrix Treatment Program in Iran: A Cox Proportional Hazard Model Application, BMC Psychiatry (2016)
39. Is Opium Addiction a Risk Factor for Deep Vein Thrombosis? a Case-Control Study, Blood Coagulation and Fibrinolysis (2010)
40. Effectiveness of Emotion Regulation Group Therapy on Craving, Emotion Problems, and Marital Satisfaction in Patients With Substance Use Disorders: A Randomized Clinical Trial, Iranian Journal of Psychiatry (2019)
41. Effectiveness of Transactional Analysis Intervention on Treatment Acceptance, Primary Maladaptive Schema, and Interpersonal Problems in Patients Under Methadone Maintenance Treatment, Journal of Substance Use (2022)
42. The Effect of Aerobic Exercise on Dopamine Release in Periaqueductal Gray Region Following the Use of Morphine in Rat, Journal of Isfahan Medical School (2018)
43. The Effect of the Blockage of the Receptors of Glutamate N-Methyl-D-Aspartate (Nmda) in Prefrontal Cortex on Morphine Tendency in Male Rat, Journal of Isfahan Medical School (2016)
44. Effect of Treadmill Running on Morphine Dependence Before and After Medial Prefrontal Cortex Lesion in Rats, Asian Journal of Sports Medicine (2016)
45. Effects of Dextromethorphan on Reducing Methadone Dosage in Opium Addicts Undergoing Methadone Maintenance Therapy: A Double Blind Randomized Clinical Trial, Journal of Research in Medical Sciences (2011)
46. Effects of Roy's Adaptation Model on Quality of Life in People With Opioid Abuse Under Methadone Maintenance Treatment: A Randomized Trial, Ethiopian journal of health sciences (2023)
47. The Role of Medial Prefrontal Cortex and Ventral Tegmental Areas in Withdrawal Syndrome in Morphine Addicted Male Rats, Journal of Isfahan Medical School (2020)
48. Oral Health Status and Its Determinants Among Opiate Dependents: A Cross-Sectional Study, BMC Oral Health (2019)
49. The Role of Nmda Glutamate Receptors in the Lateral Habenula on Morphine-Induced Conditioned Place Preference in Rats, Synapse (2023)
50. Bupropion Efficacy on Sexual Dysfunction Among Male Patients on Methadone Maintenance Therapy: A Double-Blind Placebo-Controlled Trial, Sexual and Relationship Therapy (2015)